Characterization of cellular and molecular responses of human glioblastoma to Transforming Growth Factor-β signalling pathway inhibition
Glioblastoma Multiforme (GBM) is the most prevalent malignant brain tumour accounting for 60-70% of all gliomas. Improvements in survival over the past 100 years can be measured only in weeks, and current achieved median survival ranges only 12-15 months. A hallmark of this malignancy is the intr...
| Autores principales: | , , |
|---|---|
| Formato: | info:eu-repo/semantics/doctoralThesis |
| Lenguaje: | eng |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10171/41418 |